A capsular polysaccharide from a healthy human microbiota member activates a Lag-3-NK cell axis to restrain colon cancer and augment immunotherapy

Allison M. Weis(Huntsman Cancer Institute), June L. Round(Huntsman Cancer Institute), Doratha A. Byrd(Moffitt Cancer Center), David Shibata(St. Jude Children's Research Hospital), Rickesha Bell(Huntsman Cancer Institute), Emmanuel Stephen‐Victor(Boston Children's Hospital), Jane C. Figueiredo(University of Southern California), Sheetal Hardikar(University of Utah), Ryan M. O’Connell(University of California, Los Angeles), Christopher I. Li(Fred Hutch Cancer Center), Biljana Gigic(Heidelberg University), Kaylyn M. Bauer(Huntsman Cancer Institute), Kathleen L. Arnolds(University of Colorado Anschutz Medical Campus), Jennifer Hampton Hill(University of Utah), Erin M. Siegel(Moffitt Cancer Center), William W. Tang(University of Utah), Van Huy Tran(Huntsman Cancer Institute), Jennifer Ose(Hochschule Hannover), H. Atakan Ekiz(Izmir Institute of Technology), Catherine Lozupone(Colorado School of Public Health), W. Zac Stephens(Huntsman Cancer Institute), Adetunji T. Toriola(Washington University in St. Louis), Kendra A. Klag(University of Utah), Logan Barrios(Huntsman Cancer Institute), Martin Schneider(Heidelberg University), Eric A. Swanson(MIT Lincoln Laboratory), Cornelia M. Ulrich(Huntsman Cancer Institute), Kyla S. Ost(University of Colorado Anschutz Medical Campus), Morgan Harwood(Huntsman Cancer Institute), D. Garrett Brown(Huntsman Cancer Institute)
Cell Reports
August 23, 2025
Cited by 8


Related Papers